StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.04−0.04 (-3.70%)

Close on Nov 18, 2026Market cap $6.81MP/E –Yield –

Exicure price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Exicure's price to sales ratio was 126.0× on Apr 30, 2025, against 0.2× a year earlier. Over the last 5 years it ranged from 0.2× to 259.0×, with a median of 11.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 2025126.0×+66.6
2024Dec 31, 202459.4×+59.2
2023Dec 29, 20230.2×−0.4
2022Dec 30, 20220.6×−26.6
2021Oct 29, 202127.2×+18.0
2020Dec 31, 20209.2×−209.9
2019Dec 31, 2019219.1×+148.0
2018Dec 31, 201871.2×–

More Exicure figures

See a number that looks wrong?